Pediatric Infectious Disease

Register      Login

VOLUME 4 , ISSUE 4 ( October-December, 2022 ) > List of Articles

Original Article

Seroprevalence of SARS-CoV-2 in Children Admitted to a Pediatric Ward of an Urban Hospital

Rama Kaja, Surendranath Mallavalli

Keywords : Lymphadenitis, Pediatric, SARS-CoV-2 seroprevalence

Citation Information : Kaja R, Mallavalli S. Seroprevalence of SARS-CoV-2 in Children Admitted to a Pediatric Ward of an Urban Hospital. Pediatr Inf Dis 2022; 4 (4):130-132.

DOI: 10.5005/jp-journals-10081-1341

License: CC BY-NC 4.0

Published Online: 31-12-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

A seroprevalence of SARS-CoV-2 study among pediatric patients in a South Indian urban hospital found 37% of children to be COVID-19 IgG positive in a 7-month period. Data reveals widespread asymptomatic infection among children. We may achieve herd immunity faster than other countries which might also increase vaccine effectiveness. Manifestations like suppurative cervical lymphadenitis and intussusception were seen with greater frequency in our study sample. Aim: To study the seroprevalence of SARS-CoV-2 among pediatric patients admitted in an urban hospital in South India. Methods: An analytical study was conducted using medical records of children admitted for various conditions in the pediatric ward of our non-COVID-19 hospital from July 2020 through January 2021, a total of 7 months. All patients were tested for SARS-CoV-2 antibodies using the Cellex q Cassette rapid test. Those with a positive RT-PCR or positive IgM were referred to designated hospitals. Result: We found 37% of the children to be COVID-19 IgG positive. Manifestations like suppurative cervical lymphadenitis and intussusception were seen with greater frequency in our study sample. Conclusion: Data reveals widespread asymptomatic infection among children. We may achieve herd immunity faster than other countries which might also increase vaccine effectiveness.


PDF Share
  1. Zimmermann P, Curtis N. COVID-19 in children, pregnancy and neonates: a review of epidemiologic and clinical features. Pediatr Infect Dis J 2020;39(6):469–477. DOI: 10.1097/INF.0000000000002700
  2. Roarty C, Tonry C, McFetridge L, et al. Kinetics and seroprevalence of SARS-CoV-2 antibodies in children. Lancet Infect Dis 2021;21(6):e143. DOI: 10.1016/S1473-3099(20)30884-7. Accessed February 11, 2021.
  3. Buonsenso D, Valentini P, De Rose C, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposition to adults with COVID-19: preliminary findings. Pediatr Pulmonol 2021;56(6):1374–1377. DOI: 10.1002/ppul.25280. [Epub ahead of print]
  4. Murhekar MV, Bhatnagar T, Selvaraju S, et al. SARS-CoV-2 antibody seroprevalence in India, August–September 2020: findings from the second nationwide household serosurvey Lancet 2021;9(3):E257–E266. DOI: 10.1016/S2214–109X 203,0544–1. Accessed February 11, 2021.
  5. Mohanan M, Malani A, Krishnan K, et al. Prevalence of SARS-CoV-2 in Karnataka, India. JAMA 2021;325(10):1001–1003. DOI: 10.1001/jama.2021.0332
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.